- You can view the full Allergan Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Estimates for erenumab annual sales run as high as $2.3 billion.
The Trump administration's executive order on tax regulations could revive the defunct Allergan-Pfizer merger.